Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Gross Domestic Knowledge Product: Redefining India’s Knowledge Economy
- 2 Rapid Growth of AI: Implications for the Environment
- 3 India and Qatar: A New Era of Collaboration
- 4 2025: The Year of Defence Reforms
- 5 Gender-Inclusive Agritech: Empowering Women Farmers
- 6 Quantum Economy: Redefining Economic Landscapes
- 7 PwDs in India: Challenges and Empowerment Initiatives
- 8 India State of Forest Report 2023: Gains and Concerns
- 9 Groundwater Contamination in India: An Emerging Challenge
- 10 G20 Rio de Janeiro Leaders' Declaration: Towards Resilient & Inclusive Global Growth